Search results
Results from the WOW.Com Content Network
As the leading resource in surgical oncology, Annals of Surgical Oncology, emphasizes clinical and translational research advancing surgical cancer care. The official journal of the Society of Surgical Oncology, ASO delivers high author satisfaction and a global audience.
As the leading resource in surgical oncology, Annals of Surgical Oncology, emphasizes clinical and translational research advancing surgical cancer care.
A leading peer-reviewed journal in Oncology and Surgery, ASO features original articles on the latest advances in oncology for cancer surgeons from all specialties. Leading subject areas of ASO include Gastrointestinal Oncology, Breast Oncology, Hepatobiliary Tumors, Colorectal Cancer, Thoracic Oncology, and Translational Research.
Society of Surgical Oncology: SSO 2022 – International Conference on Surgical Cancer Care. Issue 4 April 2022; Issue 1 supplement April 2022. The American Society of Breast Surgeons Official Proceedings, Volume XXIII. 2022 Annual Meeting. Issue 3 March 2022; Issue 2 February 2022; Issue 1 January 2022; Volume 28 January - December 2021 Jan ...
As the leading resource in surgical oncology, Annals of Surgical Oncology, emphasizes clinical and translational research advancing surgical cancer care.
Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Tzu-Pin Lu.
As the leading resource in surgical oncology, Annals of Surgical Oncology, emphasizes clinical and translational research advancing surgical cancer care.
Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Cancer. Kosei Takagi. Tomokazu Fuji. Toshiyoshi Fujiwara. Pancreatic Tumors. Open Access. Published: 27 September 2024.
The Official Journal of the American Society of Breast Surgeons. 2024 Editorial Board Roster. Editor-in-Chief. Kelly M. McMasters, MD, PhD. University of Kentucky. Louisville, KY, USA. Executive Editor. Mark S. Roh, MD. Lee Health.
Annals of Surgical Oncology - Uveal melanoma (UM) has a poor prognosis once liver metastases occur. The melphalan/Hepatic Delivery System (melphalan/HDS) is a drug/device combination used for...